Long-term survival in advanced-stage uterine papillary serous carcinoma

被引:0
|
作者
Holman, Laura L. [1 ]
Iglesias, David A. [1 ]
Soliman, Pamela T. [1 ]
Pal, Navdeep [1 ]
Klopp, Ann [1 ]
Broaddus, Russell [1 ]
Ayeni, Tina [1 ]
Fleming, Nicole Dierschke [1 ]
Munsell, Mark F. [1 ]
Lu, Karen H. [1 ]
Westin, Shannon Neville [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5596
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Radiation therapy improves survival in early stage uterine papillary serous and clear cell carcinoma
    Kim, A.
    Rineer, J.
    Schreiber, D.
    Vongtama, D.
    Han, P.
    Choi, K.
    Rotman, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S19 - S20
  • [32] Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers
    Berchuck, A
    Iversen, ES
    Lancaster, JM
    Pittman, J
    Luo, JQ
    Lee, P
    Murphy, S
    Dressman, HK
    Febbo, PG
    West, M
    Nevins, JR
    Marks, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3686 - 3696
  • [33] Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes
    Fader, Amanda Nickles
    Nagel, Christa
    Axtell, Allison E.
    Zanotti, Kristine M.
    Kelley, Joseph L.
    Moore, Kathleen N.
    Secord, Angeles Alvarez
    Walsh, Christine S.
    Huh, Warner K.
    Gehrig, Paola A.
    Gibbons, Heidi
    Rose, Peter G.
    Havrilesky, Laura J.
    Tuller, Erin
    Drake, Richard D.
    Bottsford-Miller, Justin
    O'Malley, David M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 558 - 562
  • [34] Genomic profiling of patients with advanced-stage uterine serous carcinoma: Is there difference in genomic signature when stratified by outcome?
    Mahdi, H.
    Ni, Y.
    Gylfe, A. E.
    Bloom, K.
    Shinbrot, E.
    Rose, P. G.
    Tang, W. H. W.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 236 - 236
  • [35] Limiting adjuvant chemotherapy in stage IA uterine papillary serous carcinoma
    Goodwin, Halle
    Mujumdar, Vaidehi
    Chen, Jane
    Brown, Jubilee
    Crane, Erin
    Lees, Brittany
    Puechl, Allison
    Casablanca, Yovanni
    Naumann, R. Wendel
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S431 - S431
  • [36] Role of cytoreduction in stage III and IV uterine papillary serous carcinoma
    Thomas, M. Bijoy
    Mariani, Andrea
    Cliby, William A.
    Keeney, Gary L.
    Podratz, Karl C.
    Dowdy, Sean C.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 190 - 193
  • [37] Adding trastuzumab to carboplatin and paclitaxel improves overall survival in advanced-stage HER2/NEU overexpressing uterine serous carcinoma or carcinosarcoma
    Lu, Ting-Fang
    Lou, Sun
    Shih, Yu-Hsiang
    Chen, Yen-Fu
    Fan, Chun Ting
    Wang, Shao-Jing
    Hsu, Shih-Tien
    Liu, Chin-Ku
    Hwang, Sheau-Feng
    Lu, Chien-Hsing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A45 - A46
  • [38] Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum
    Look, M
    Chang, D
    Sugarbaker, PH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (01) : 35 - 41
  • [39] Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum
    Look, M
    Chang, D
    Sugarbaker, PH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) : 764 - 770
  • [40] Optimal surgical debulking in uterine papillary serous carcinoma affects survival
    Patsavas, Kristia
    Woessner, Jessica
    Gielda, Benjamin
    Rotmensch, Jacob
    Yordan, Edgardo
    Bitterman, Pincas
    Guirguis, Alfred
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 581 - 585